RE: A further read ..30 Apr 2025 22:36
The NDA theory doesn’t sit with my own thoughts.
There appears to be either a sense of supreme confidence in readiness to approaching suitors , or there is panic and it’s grasping at straws, in the hope someone throws SAR a lifeline. And all the in betweens.
There may be no desire to take tyk2 into phase 2 and beyond, but give it’s all due diligence to be confident of success, in order to sell.
CHK1 has got data at phase 2, and shows good results in anogenal cancer ( unmet need) and not an amazing much of anything else.
Now to bring in Skil and the BBB, for myself, is just showcasing the pharma world, what we have.
Love peace and harmony
Tyk2 at the site, not next to it. Patented.